Berkay Yesilyurt
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: May 06, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).
Journal: JCO global oncology
Published: March 26, 2026
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.
Journal: Medicina (Kaunas, Lithuania)
Published: March 22, 2026
Prognostic Value of the Lung Immune Prognostic Index in Metastatic Renal Cell Carcinoma Treated With Second-Line Immunotherapy.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: February 19, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).
Journal: International journal of cancer
Published: February 09, 2026
Evaluation of machine learning algorithms for renin-angiotensin-aldosterone system inhibitors associated renal adverse event prediction.
Journal: European journal of internal medicine
Published: March 31, 2023
Evaluation of early unplanned readmissions and predisposing factors in an oncology clinic.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 02, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026